A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus

• Auteurs principaux: Bang Sun-Hwi (Auteur), Yoon Jeung-Won (Auteur), Cho Chong-Kwan (Auteur), Shin Ji-Eun (Auteur), Lee Yeon-Weol (Auteur), Yoo Hwa-Seung (Auteur)
• Format: Livre
• Publié: Korean Pharmacopuncture Institute, 2012-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background and Objectives: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus (HAP) has been developed...